At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
HIV/AIDS
HIV/AIDS
-
-
Fighting the Syndemic: Addressing Opioid Use Disorder and Decreasing HIV Go Hand-in- Hand
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV. -
Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH. -
Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady. -
Neurocognitive Conditions Among People Living With HIV
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Latest News
Patient May Have Naturally Achieved a Sterilizing Cure for HIV infection
Researchers evaluated the virologic and immunologic characteristics of a patient with previously confirmed HIV infection who had an undetectable HIV viral load for more than 7 years after discontinuing antiretroviral therapy.
Effects of HIV Pre-Exposure Prophylaxis on High-Risk Sexual Behaviors in Men Who Have Sex With Men
Investigators conducted a study to assess the rates of high-risk sexual behavior and sexually transmitted infections among men who have sex with men before and after the introduction of HIV pre-exposure prophylaxis.
Cerebrospinal Fluid vs Plasma HIV RNA Viral Loads in Patients With Untreated HIV Infection
Researchers conducted a study to determine whether patients with untreated HIV infection have consistently decreased cerebrospinal fluid HIV RNA viral loads vs plasma HIV RNA throughout various stages of the disease.
Hypertension Risk Factors in Young Adults With Perinatal HIV Infection
Researchers conducted a study to determine the socio-demographic, clinical, virologic, and immunologic risk factors associated with systemic hypertension in patients with perinatal HIV infection.
Optimal Dosing of Rifampicin/Isoniazid/Pyrazinamide in Children With Tuberculosis
Investigators conducted a study to determine the optimal fixed-dose combination of rifampicin/isoniazid/pyrazinamide in children with tuberculosis infection.
Effect of Antiretroviral Therapy on Gut Microbiota in Children With HIV Infection
Researchers conducted a study to assess the effect of antiretroviral therapy on the gut microbiota in children with HIV infection.
Associations Found Between HIV Infection and Impaired Pulmonary Gas Exchange
Investigators assessed the relationship between HIV infection and impaired pulmonary gas exchange, as well as the influence HIV has on the diffusing capacity of the lungs for carbon monoxide in patients with and without comorbid chronic obstructive pulmonary disease.
Outcomes of a Tailored HIV Pre-Exposure Prophylaxis Service for Individuals Who Inject Drugs
Researchers conducted a study that assessed the use of an HIV pre-exposure prophylaxis service tailored to individuals who inject drugs.
Effect of Routine Use of Lubricants on Vaginal Cytokine and Microbiota Profiles
Researchers conducted a study that compared vaginal cytokine and microbiota profiles before and after condomless vaginal intercourse between women who use vaginal lubricants vs those who do not.
Gut Dysbiosis May Affect Distal Neuropathic Pain Development in HIV
Gut dysbiosis may contribute to the development of distal neuropathic pain in people living with HIV.
Impact of Diet Among Patients With HIV at Risk for Antiretroviral Therapy-Associated Weight Gain
Investigators conducted a study to determine the effects of antiretroviral therapy on weight gain in patients with HIV infection.
Prevalence of Noncalcified Coronary Plaques and CAC in People Living With HIV
This meta-analysis examined the burden of subclinical CV disease in people living with HIV.
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in African American Adults With HIV Infection
Researchers conducted a study to assess virologic outcomes and adherence associated with treatment with bictegravir/emtricitabine/tenofovir alafenamide in African American patients with HIV infection.
Efficacy of First-Line Treatment With Dolutegravir/Lamivudine in Patients With Newly Diagnosed HIV Infection
Investigators conducted a secondary analysis that assessed virologic outcomes following 48 weeks of first-line treatment with dolutegravir/lamivudine in patients with newly diagnosed HIV infection.
Effects of Ritonavir-Boosted Darunavir vs Doravirine in Patients With HIV Infection
Researchers conducted a study that compared virologic suppression, lipid control, and safety profiles of patients with HIV infection who switch from ritonavir-boosted darunavir to doravirine (DOR) therapy vs those who continued DOR therapy.
Two-Drug Regimen Increases Risk for Virologic Failure in Individuals With HIV Infection
Researchers conducted a study that included patients with HIV infection who previously achieved virologic suppression to compare the risk for virologic failure among those who switch to a single-tablet 2-drug regimen vs those who switch to a single-tablet 3-drug regimen.
Risk for Hypertriglyceridemia in Patients With HIV Infection Treated With Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy
Researchers conducted a study to determine whether integrase strand transfer inhibitor-based antiretroviral therapy is associated with lipid changes in patients with HIV infection.
Efficacy of Long-Acting Cabotegravir Plus Rilpivirine in Patients With HIV Coinfected With Asymptomatic Hepatitis C
Researchers sought to determine the safety and efficacy of treatment with long-acting cabotegravir plus rilpivirine in patients with HIV coinfected with asymptomatic hepatitis c virus.
Increased Persistence, Re-Initiation of HIV Pre-Exposure Prophylaxis Found Among Patients Treated With Emtricitabine/Tenofovir Alafenamide
Investigators conducted a study that compared the rate of persistence and re-initiation of HIV pre-exposure prophylaxis among patients treated with emtricitabine/tenofovir alafenamide vs those treated with emtricitabine/tenofovir disoproxil fumarate.
Pharmacokinetics of a Long-Acting Monthly Injection of Rilpivirine in Patients With HIV Infection
Researchers conducted a study to assess the pharmacokinetics of a long-acting formulation of rilpivirine for the treatment of patients with HIV infection.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...